Tracy Wiczer

1.1k total citations
19 papers, 394 citations indexed

About

Tracy Wiczer is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Tracy Wiczer has authored 19 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 5 papers in Hematology and 4 papers in Molecular Biology. Recurrent topics in Tracy Wiczer's work include Chronic Lymphocytic Leukemia Research (14 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Lymphoma Diagnosis and Treatment (3 papers). Tracy Wiczer is often cited by papers focused on Chronic Lymphocytic Leukemia Research (14 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Lymphoma Diagnosis and Treatment (3 papers). Tracy Wiczer collaborates with scholars based in United States. Tracy Wiczer's co-authors include Kerry A. Rogers, Jennifer A. Woyach, Farrukh T. Awan, John C. Byrd, Seema A. Bhat, Daniel Addison, Kyle Porter, Kami J. Maddocks, Gary Phillips and Avirup Guha and has published in prestigious journals such as Blood, Leukemia and Journal of Hematology & Oncology.

In The Last Decade

Tracy Wiczer

18 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tracy Wiczer United States 7 212 182 118 75 63 19 394
A. Franke Germany 11 117 0.6× 103 0.6× 135 1.1× 31 0.4× 107 1.7× 28 362
Takashi Ando Japan 11 59 0.3× 111 0.6× 72 0.6× 33 0.4× 17 0.3× 19 502
Hyoung Soo Choi South Korea 13 140 0.7× 26 0.1× 204 1.7× 53 0.7× 33 0.5× 42 418
Huub P J Willems Netherlands 5 154 0.7× 35 0.2× 267 2.3× 49 0.7× 27 0.4× 7 529
Annmarie Wesley Sweden 5 60 0.3× 78 0.4× 99 0.8× 29 0.4× 23 0.4× 5 488
S J Passmore United Kingdom 8 80 0.4× 32 0.2× 236 2.0× 37 0.5× 46 0.7× 10 439
Ari Shimizu Japan 12 68 0.3× 88 0.5× 86 0.7× 20 0.3× 7 0.1× 29 381
L. Heimans Netherlands 13 98 0.5× 81 0.4× 156 1.3× 18 0.2× 23 0.4× 29 538
Simona Stancu Romania 13 121 0.6× 44 0.2× 191 1.6× 29 0.4× 19 0.3× 44 487
S K Mak China 7 44 0.2× 60 0.3× 54 0.5× 38 0.5× 60 1.0× 12 385

Countries citing papers authored by Tracy Wiczer

Since Specialization
Citations

This map shows the geographic impact of Tracy Wiczer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tracy Wiczer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tracy Wiczer more than expected).

Fields of papers citing papers by Tracy Wiczer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tracy Wiczer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tracy Wiczer. The network helps show where Tracy Wiczer may publish in the future.

Co-authorship network of co-authors of Tracy Wiczer

This figure shows the co-authorship network connecting the top 25 collaborators of Tracy Wiczer. A scholar is included among the top collaborators of Tracy Wiczer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tracy Wiczer. Tracy Wiczer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ruz, Patrick, Adam S. Kittai, Kerry A. Rogers, et al.. (2024). Atrial fibrillation burden and clinical outcomes following BTK inhibitor initiation. Leukemia. 38(10). 2141–2149. 5 indexed citations
2.
3.
Wiczer, Tracy, et al.. (2023). Successful obinutuzumab administration after rituximab discontinuation due to intolerance in patients with hematologic disorders. Blood Advances. 7(14). 3431–3434. 4 indexed citations
4.
Bhat, Seema A., Marilly Palettas, Tracy Wiczer, et al.. (2022). Ventricular arrhythmias and sudden death events following acalabrutinib initiation. Blood. 140(20). 2142–2145. 46 indexed citations
5.
Zhao, Qiuhong, Tracy Wiczer, Marilly Palettas, et al.. (2022). Hypertension and incident cardiovascular events after next-generation BTKi therapy initiation. Journal of Hematology & Oncology. 15(1). 92–92. 21 indexed citations
6.
Wiczer, Tracy, Marilly Palettas, Seema A. Bhat, et al.. (2021). Evaluation of the Incidence and Risk Factors Associated with Bleeding Events in Patients Receiving Acalabrutinib Therapy. Blood. 138(Supplement 1). 3729–3729. 4 indexed citations
7.
Koenig, Kristin L, Ying Huang, Seema A. Bhat, et al.. (2020). Safety of venetoclax rapid dose escalation in CLL patients previously treated with B-cell receptor signaling antagonists. Blood Advances. 4(19). 4860–4863. 14 indexed citations
8.
Wiczer, Tracy, Marilly Palettas, James S. Blachly, et al.. (2020). Evaluation of the Incidence and Risk Factors Associated with Major Cardiovascular Events in Patients Receiving Acalabrutinib Therapy. Blood. 136(Supplement 1). 29–30. 1 indexed citations
9.
Wiczer, Tracy, et al.. (2019). Managing Addiction: Guidelines for Patients With Cancer. Clinical journal of oncology nursing. 23(6). 655–658. 5 indexed citations
10.
Koenig, Kristin L, Seema A. Bhat, John C. Byrd, et al.. (2019). Rapid Dose Escalation of Venetoclax in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Previously Treated with B-Cell Receptor Inhibitor Therapy. Blood. 134(Supplement_1). 3045–3045. 1 indexed citations
11.
Wiczer, Tracy, Kyle Porter, Devin Haddad, et al.. (2019). Hypertension and incident cardiovascular events following ibrutinib initiation. Blood. 134(22). 1919–1928. 170 indexed citations
12.
Zhao, Qiuhong, Tracy Wiczer, John C. Byrd, et al.. (2018). Incidence, Type, and Management of Venous and Arterial Thrombosis during Ibrutinib Treatment. Blood. 132(Supplement 1). 3148–3148. 1 indexed citations
13.
14.
Wiczer, Tracy, Devin Haddad, Avirup Guha, et al.. (2018). Hypertension Development, Management, and Cardiovascular Events Following Ibrutinib Initiation for Hematologic Malignancies. Blood. 132(Supplement 1). 4423–4423. 1 indexed citations
15.
Wiczer, Tracy, et al.. (2018). Initial romiplostim dosing and time to platelet response in patients with treatment refractory immune thrombocytopenia. Journal of Oncology Pharmacy Practice. 25(3). 567–576. 6 indexed citations
16.
Rogers, Kerry A., Luay Mousa, Qiuhong Zhao, et al.. (2017). Incidence and Type of Opportunistic Infections during Ibrutinib Treatment at a Single Academic Center. Blood. 130(Suppl_1). 830–830. 23 indexed citations
17.
18.
Wiczer, Tracy, Qiuhong Zhao, Amy S. Ruppert, et al.. (2016). Management and Outcomes of Atrial Fibrillation in Patients Receiving Ibrutinib for Hematologic Malignancies at a Single Center. Blood. 128(22). 2040–2040. 1 indexed citations
19.
Wiczer, Tracy, et al.. (2015). Evaluation of incidence and risk factors for high-dose methotrexate-induced nephrotoxicity. Journal of Oncology Pharmacy Practice. 22(3). 430–436. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Franke Breakdown of academic impact, for papers by Takashi Ando Breakdown of academic impact, for papers by Hyoung Soo Choi Breakdown of academic impact, for papers by Huub P J Willems Breakdown of academic impact, for papers by Annmarie Wesley Breakdown of academic impact, for papers by S J Passmore Breakdown of academic impact, for papers by Ari Shimizu Breakdown of academic impact, for papers by L. Heimans Breakdown of academic impact, for papers by Simona Stancu Breakdown of academic impact, for papers by S K Mak
Rankless by CCL
2026